The social context of drinking among LGBT+ people
Professor Carol Emslie and David Barbour discuss research on gender, identity and drinking, and the disproportionate impact of substance use in the LGBT+ community.
Rechercher
European Drug Report 2023: Trends and Developments
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national...
Seminar on Youth Participation in Substance Use Prevention
To build an affluent society, the youth must be involved in prevention of substance - Director General, Department of Narcotics Control
Youth is the time for our brain to grow and develop. Using of substances at a young age affect brain...
No Smoking day commemoration by Pakistan Youth Organization
Pakistan Youth Organization has organized seminar on eve of international no Smoking day in collaboration with Freedom drug treatment & rehab Centre, Gujranwala Pakistan on 31st May, 2023 at Freedom Rehab. Sufi Muhammad Javed, Sana Ullah...
Faits saillants du Rapport mondial sur les drogues 2023 de l'ONUDC
Participez à notre prochain webinaire présentant les points forts de l'édition 2023 du Rapport mondial sur les drogues de l'ONUDC.
Traitement et prévention des troubles liés à l’utilisation de substances en milieu de travail
ISSUP Kenya présente son webinaire sur la consommation de substances sur le lieu de travail.
MPSP se manifesta contra a descriminalização do porte de drogas para consumo pessoal
Dr. Mario Luiz Sarrubbo, Procurador-Geral da Justiça do Estado de São Paulo, protocolizou um memorial no Supremo Tribunal Federal – STF com o posicionamento do Ministério Público paulista sobre a pauta que trata da possível...
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study
Abstract
Background
The COVID-19 pandemic disrupted healthcare and substance use services engagement, including primary and mental health services as well as residential and outpatient drug treatment. Women who inject drugs (WWID) face...
Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder
Abstract
Importance Suicidal behavior is a significant clinical concern in individuals with borderline personality disorder (BPD), but the effectiveness of pharmacotherapy on reducing suicide risk has remained unknown.
Objective To...
Continuum of Care in Recovery
ISSUP Botswana present their Webinar on Continuum of Care in Recovery.
Accounts of women identified as drinking at ‘high risk’ during pregnancy
Drinking alcohol during pregnancy is associated with Foetal Alcohol Spectrum Disorders (FASD), and women who drink at higher levels are more likely to have a baby with FASD.
Efforts to better understand and respond to ‘high risk’ drinking...
Webinaire sur la prévention de la toxicomanie chez les jeunes
L’International Society of Substance Use Professionals (ISSUP) Indonesia et l’Indonesia International Training and Treatment Centre (ITTC) ont organisé ensemble le deuxième webinaire sur la « Prévention de la toxicomanie chez les jeunes »...
Indonesia's INEP Plus Online Training
ISSUP Indonesia organized the Introduction to Evidence-Based Prevention (INEP) Online Course as a national-level training in Indonesia with 17 participants. The training, conducted by Dr.dr. Kristiana Siste, SpKJ, and Dr. Elvina K...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
La FDA approuve une nouvelle option de traitement à la buprénorphine pour le trouble lié à l’utilisation d’opioïdes
Pour diffusion immédiate : 24 mai 2023
Aujourd’hui, la Food and Drug Administration (FDA) des États-Unis a approuvé l’injection sous-cutanée à libération prolongée de Brixadi (buprénorphine) pour traiter les troubles modérés à graves liés...
Covering Substance Use and Addiction Responsibly
Stories about substance use and addiction can be among the thorniest that health and science reporters encounter. This topic carries a long history of marginalizing the people most directly affected. In addition, deeply ingrained societal misconceptions about substance use make it difficult to separate fact from fiction
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Assessment of Medical Cannabis and Health-Related Quality of Life
Abstract
Importance The use of cannabis as a medicine is becoming increasingly prevalent. Given the diverse range of conditions being treated with medical cannabis, as well as the vast array of products and dose forms available, clinical...
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people
Abstract
Background
SMART (Self-Management and Recovery Training) Recovery is a mutual-aid program informed by cognitive behaviour therapy and motivational interviewing that provides support for a range of addictive behaviours. SMART...